Macrophage Involvement in Systemic Sclerosis: Do We Need More Evidence?

Curr Rheumatol Rep. 2016 Jan;18(1):2. doi: 10.1007/s11926-015-0554-8.

Abstract

The pathogenesis of systemic sclerosis is still unknown, although immune cells, mainly macrophages/monocytes, may have an important role in initiating and/or perpetuating the disease. Macrophages and monocytes are often classified as pro-inflammatory M1 phenotype or classic activation and pro-fibrotic/anti-inflammatory M2 phenotype or alternative activation. In this review, we highlighted the most relevant research regarding the involvement of macrophages/monocytes in the pathogenesis of this complex disease.

Keywords: Fibrosis; Macrophages; Monocytes; Pathogenesis; Scleroderma; Systemic sclerosis.

Publication types

  • Review

MeSH terms

  • Evidence-Based Medicine / methods
  • Humans
  • Lung Diseases, Interstitial / etiology
  • Lung Diseases, Interstitial / immunology
  • Macrophages / immunology*
  • Scleroderma, Systemic / complications
  • Scleroderma, Systemic / immunology*
  • Skin / immunology